BCM
PFE icon

Brookstone Capital Management’s Pfizer PFE Stock Holding History

Brookstone Capital Management’s Portfolio PFE Stock Details PFE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$6.57M Sell
272,912
-7,367
-3% -$193K 0.07% 289
2026
Q1 		$7.87M Buy
280,279
+9,762
+4% +$260K 0.09% 252
2025
Q4 		$6.74M Buy
270,517
+1,136
+0.4% +$28.6K 0.08% 262
2025
Q3 		$6.86M Buy
269,381
+154,286
+134% +$3.81M 0.08% 257
2025
Q2 		$2.79M Sell
115,095
-1,651
-1% -$38.5K 0.04% 364
2025
Q1 		$2.96M Buy
116,746
+7,593
+7% +$199K 0.04% 341
2024
Q4 		$2.9M Sell
109,153
-14,777
-12% -$401K 0.04% 325
2024
Q3 		$3.59M Buy
123,930
+1,876
+2% +$54.7K 0.05% 294
2024
Q2 		$3.67M Buy
122,054
+33,024
+37% +$909K 0.06% 279
2024
Q1 		$2.47M Sell
89,030
-342,976
-79% -$9.52M 0.04% 326
2023
Q4 		$12.4M Sell
432,006
-20,346
-4% -$615K 0.24% 110
2023
Q3 		$14.1M Buy
452,352
+212,369
+88% +$7.51M 0.31% 84
2023
Q2 		$8.53M Buy
239,983
+139,895
+140% +$5.45M 0.17% 143
2023
Q1 		$4.12M Sell
100,088
-4,332
-4% -$187K 0.08% 218
2022
Q4 		$5.32M Buy
104,420
+2,890
+3% +$139K 0.11% 170
2022
Q3 		$4.27M Sell
101,530
-3,025
-3% -$147K 0.1% 188
2022
Q2 		$5.56M Sell
104,555
-1,534
-1% -$78.2K 0.12% 163
2022
Q1 		$5.72M Sell
106,089
-64,792
-38% -$3.36M 0.11% 176
2021
Q4 		$9.52M Sell
170,881
-8,273
-5% -$410K 0.16% 124
2021
Q3 		$7.42M Sell
179,154
-1,097
-0.6% -$48.6K 0.13% 139
2021
Q2 		$7.15M Buy
180,251
+33,061
+22% +$1.29M 0.13% 147
2021
Q1 		$5.33M Buy
147,190
+7,933
+6% +$282K 0.2% 99
2020
Q4 		$5.13M Buy
139,257
+5,168
+4% +$190K 0.2% 94
2020
Q3 		$4.67M Buy
134,089
+32,729
+32% +$1.15M 0.22% 71
2020
Q2 		$3.15M Sell
101,360
-17,631
-15% -$599K 0.2% 77
2020
Q1 		$3.69M Sell
118,991
-22,301
-16% -$760K 0.21% 64
2019
Q4 		$5.25M Sell
141,292
-9,425
-6% -$336K 0.27% 58
2019
Q3 		$5.14M Buy
150,717
+4,804
+3% +$175K 0.28% 56
2019
Q2 		$6M Buy
145,913
+61,990
+74% +$2.46M 0.35% 48
2019
Q1 		$3.38M Sell
83,923
-690
-0.8% -$27.6K 0.22% 72
2018
Q4 		$3.5M Sell
84,613
-95,663
-53% -$3.97M 0.27% 69
2018
Q3 		$7.54M Sell
180,276
-30,301
-14% -$1.17M 0.57% 37
2018
Q2 		$7.25M Sell
210,577
-20,896
-9% -$714K 0.63% 36
2018
Q1 		$7.79M Buy
231,473
+11,352
+5% +$390K 0.71% 31
2017
Q4 		$7.56M Buy
220,121
+7,080
+3% +$241K 0.68% 34
2017
Q3 		$7.22M Sell
213,041
-6,649
-3% -$214K 0.65% 39
2017
Q2 		$7M Sell
219,690
-2,784
-1% -$87.8K 0.67% 42
2017
Q1 		$7.22M Buy
222,474
+19,814
+10% +$625K 0.73% 43
2016
Q4 		$6.25M Buy
202,660
+36,042
+22% +$1.1M 0.69% 47
2016
Q3 		$5.35M Buy
166,618
+34,757
+26% +$1.16M 0.59% 42
2016
Q2 		$4.41M Buy
131,861
+9,388
+8% +$300K 0.58% 38
2016
Q1 		$3.44M Buy
122,473
+100,451
+456% +$2.87M 0.52% 37
2015
Q4 		$674K Buy
22,022
+146
+0.7% +$4.59K 0.13% 66
2015
Q3 		$652K Sell
21,876
-105,987
-83% -$3.4M 0.12% 53
2015
Q2 		$4.07M Buy
127,863
+22,864
+22% +$745K 0.51% 25
2015
Q1 		$3.47M Buy
104,999
+25,886
+33% +$823K 0.52% 27
2014
Q4 		$2.34M Buy
79,113
+36,774
+87% +$1.05M 0.39% 29
2014
Q3 		$1.19M Buy
42,339
+16,990
+67% +$477K 0.22% 41
2014
Q2 		$714K Buy
25,349
+953
+4% +$27.2K 0.15% 49
2014
Q1 		$743K Buy
24,396
+15,352
+170% +$458K 0.19% 45
2013
Q4 		$263K Buy
+9,044
New +$263K 0.08% 92

Other funds holding PFE

Robeco Institutional Asset Management
Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return
Swedbank
Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return
CWP
Curated Wealth Partners El Segundo, California $774M AUM 5.71% 1-Year Est. Return
Wealth Enhancement Advisory Services
Wealth Enhancement Advisory Services Plymouth, Minnesota $59.8B AUM 29.42% 1-Year Est. Return
Handelsbanken Fonder
Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return
FWIA
Fort Washington Investment Advisors Cincinnati, Ohio $19.9B AUM 22.19% 1-Year Est. Return
ORIO
Old Republic International (ORI) Chicago, Illinois $2.67B AUM 26.94% 1-Year Est. Return
CNB
Czech National Bank Prague, Czech Republic $18.3B AUM 43.04% 1-Year Est. Return
Mirae Asset Global Investments
Mirae Asset Global Investments Seoul, South Korea $67.7B AUM 51.91% 1-Year Est. Return

Brookstone Capital Management's PFE Position: Q2 2026 in Review

Brookstone Capital Management reduced its Pfizer (PFE) stake by 2.6% in Q2 2026, selling an estimated $193K and leaving 272,912 shares worth $6.57M. The position accounts for 0.07% of the portfolio, ranked #289.

Brookstone Capital Management first reported a position in PFE in Q4 2013 and has held it in 51 quarters since. The position peaked at $14.1M in Q3 2023. 705 funds tracked by Wall St. Rank hold PFE as of Q2 2026.

  • Brookstone Capital Management held 272,912 shares of Pfizer worth $6.57M as of Q2 2026.
  • Brookstone Capital Management sold 7,367 Pfizer shares in Q2 2026, an estimated $193K.
  • Pfizer made up 0.07% of Brookstone Capital Management's portfolio in Q2 2026, its #289 holding.
  • Brookstone Capital Management first reported a position in Pfizer in Q4 2013 and has held it in 51 quarters since.
  • Brookstone Capital Management's Pfizer position peaked at $14.1M in Q3 2023.
  • 705 funds tracked by Wall St. Rank held Pfizer as of Q2 2026.

Based on Brookstone Capital Management's 13F filing for Q2 2026, filed 15 Jul 2026.